“A woman dies from breast cancer every 75 seconds worldwide making it the most common cause of death among this gender.”
- Source: Susan G. Komen for the Cure
imaging
MENA Oncology Conference
Submitted by natasha99 on Wed, 16/06/2010 - 11:22What happened to the ART post?
Submitted by Anonymous on Fri, 11/06/2010 - 16:33Wasn't there a post about changes at ART, the imaging company out of Canada? Where did it go? Was it deleted?
Conference on Glaucoma & Retinopathies 2010
Submitted by bharatbookseo on Mon, 17/05/2010 - 10:25- Allergan
- Bausch & Lomb Pharma
- BsG Conference Centre
- Company Technology
- Didier Pruneau
- drug delivery
- Elena Feinstein
- Ennio Ongini
- Glaucoma
- GlaxoSmithKline
- Gunilla Norgren
- imaging
- Kay D. Rittenhouse
- Laboratory of Ophthalmology
- London
- M. Francesca Cordeiro
- National University Hospital
- Ophthalmology
- Ophthalmology
- Oxford
- Oxford Eye Hospital
- Paul Ashton
- Person Career
- Peter Adamson
- Quark Pharmaceuticals
- Risk Neville Osborne
- Sanofi -Fovea Einar Stefansson
- Selwyn Ho
- Ted Danse
- Tuyen Ong
- United Kingdom
- University College London In
- University College London
- University of Iceland
- University of Iceland
- University of Oxford M
- University of Oxford Victor Chong
- Victor Chong
Conference on Glaucoma & Retinopathies 2010
Date Info: 21st Jun 2010 to 22nd Jun 2010
Venue Info: BsG Conference Centre, London, UK
Key Speakers
Kay D. Rittenhouse, Head Translational Medicine Ophthalmology, Clinical
Development & Medical Affairs, Specialty Care Business Unit, Pfi zer
Conference on Amorphous Pharmaceutical Materials
Submitted by bharatbookseo on Mon, 17/05/2010 - 10:15- Allergan
- AMD
- Apoptosis
- Bausch & Lomb Pharma
- Bird Michael Gamlen
- Bird Michael Gamlen
- Bruckhaus Deringer LLP
- Company Technology
- Didier Pruneau
- drug delivery
- Elena Feinstein
- Ennio Ongini
- food
- Franco Sartor
- Glaucoma
- GlaxoSmithKline
- Gunilla Norgren
- healthcare
- imaging
- Institute of Food Research Dr
- Institute of Food Research Dr
- Kay D. Rittenhouse
- Laboratory of Ophthalmology
- Ljiljana Harding
- London
- M. Francesca Cordeiro
- Mark Saunders
- National University Hospital
- Ophthalmology
- Oxford
- Oxford Eye Hospital
- Paul Ashton
- Person Career
- Peter Adamson
- pharmaceutical
- Pharmaceutical Development Services
- Pharmaceutical Development Services Senior
- pharmaceuticals
- Quark Pharmaceuticals
- Risk Neville Osborne
- Roger Parker
- Rolf Hilfi
- Sanofi -Fovea Einar Stefansson
- Selwyn Ho
- Sigrid Stokbroekx
- Simon Gaisford
- Synectix Pharmaceutical Solutions
- Ted Danse
- Tuyen Ong
- United Kingdom
- University College London In
- University College London
- University of Iceland
- University of Iceland
- University of Oxford M
- University of London Mark Saunders
- University of London Mark Saunders
- University of London
- University of Oxford Victor Chong
- Victor Chong
- Wouter Pors
Conference on Amorphous Pharmaceutical Materials
Date Info: 14th Jun 2010 to 15th Jun 2010
Venue Info: BSG House, London, UK
Key Speakers
Ljiljana Harding, Inhalation & Devices Centre of Emphasis, Pfi zer
Franco Sartor, Principal scientist , GlaxoSmithKline
Conference on CNS Clinical Trials
Submitted by bharatbookseo on Thu, 14/01/2010 - 06:02- Alan M Palmer
- American College
- AstraZeneca
- BioMedical Research Dr Mark Tricklebank
- CNS
- CNS Clinical Biomarker Group
- Company Technology
- dementia
- Director Diagnostic Imaging Core Laboratory
- drug development
- drug therapies
- Elaine Rankin
- Erik Buntinx
- Fabrizio Gasparini , Sr
- GlaxoSmithKline
- Global Medical Affairs
- imaging
- Johan Wiklund
- Karl Herholz
- London
- medical imaging
- Mehdi Adineh
- MS Therapeutics
- multiple sclerosis
- neurodegenerative disorders
- Neurology
- Neuroscience
- Novartis
- Person Career
- pharmaceutical
- Samuel Agus
- Simone Braggio
- Solvay
- Statistical Science
- Therapeutics Nancy Mulligan
- United Kingdom
- University of Manchester
- Wolfson Molecular
http://www.bharatbook.com/detail.asp?id=128073&rt=Conference-on-CNS-Clin...
Conference on CNS Clinical Trials
Optimising development, management and recruitment for clinical trials in CNS
15th - 16th March 2010, BSG Conference Centre, London, UK
Background Info
Key Speakers
Dr Erik Buntinx, Managing Director and Chief Scientifi c Offi cer, PharmaNeuroBoost
New Illumina Sequencer
Submitted by Anonymous on Wed, 13/01/2010 - 06:03How will this stack up to Complete Gen and Pac Bio?